ANXA3 and laryngotracheoesophageal cleft: However, high expression of two candidates, ANXA3 and ARG1, was strongly associated with LC, and especially with late-stage LC in the last two years prior to LC diagnosis (ORs 3.47 and 5.00, respectively).